HTN’s Q2 Earnings Season Debrief

Sean Leimbach sat down with Martin Cech and Kevin O'Leary on August 20, 2026 to discuss Q2 2026 earnings season, covering AI's real ROI versus the hype, the Medicare Advantage rebound, and the employer health market's momentum.

Aug 20, 2026

Martin Cech

Keep Reading

Oct 4, 2026

•

11 min read

Weekly Health Tech Reads 10/4/26

Oura's postponed IPO, Devoted's $25 billion valuation, Cigna's specialty pharma play, the 2027 MA landscape emerges, Grindr's healthcare move, and more

Kevin O'Leary

Devoted Health valued at ~half a Humana; FQHC-focused venture fund from Facktor; MedImpact's new offerings

Oct 2, 2026

•

2 min read

Devoted Health valued at ~half a Humana; FQHC-focused venture fund from Facktor; MedImpact's new offerings

HTN Daily Brief:10/02/2026

Martin Cech, Kevin O'Leary

Cigna's Investor Day; MA plans available in Medicare Plan Finder; an ASC JV in Delaware

Oct 1, 2026

•